Studying these specific molecular markers provides a powerful approach for diagnosis and therapeutics in a vast array of cancers (TBNC, lung cancer, PCa, GBM, Rb, and HIV-associated malignancies). This evidence concerns the gene RB1 and posterior cortical atrophy.